इस उत्पाद की विस्तृत जानकारी अभी अंग्रेज़ी में उपलब्ध है।

Made by SterisWHO-GMP

Seizmet Trio 0.2

by Steris Healthcare Pvt. Ltd.

Be the first to review

Glimepiride 2 mg + Metformin Hydrochloride 500 mg + Voglibose 0.2 mg

View medicine information ↓
पैक चुनें
₹146.65₹209.5030% offinclusive of all taxes
Subscribe & save 5%Refill on your schedule · skip or cancel anytimeSave ₹7.33 every delivery
Set up autopay

Delivery estimate appears here

ManufacturerSteris Healthcare Pvt. Ltd.
Manufacturing qualityWHO-GMP verified
Expiry policyMinimum 3 months
ReviewedClinical review pending

Medicine information

उपयोग

SEIZMET TRIO 0.2 by Steris Healthcare brings together three complementary blood sugar-lowering agents in a single tablet: Glimepiride (2 mg), Metformin Hydrochloride Sustained Release (500 mg), and Voglibose (0.2 mg). This triple-action formulation addresses type 2 diabetes across three distinct physiological pathways—stimulating insulin release, overcoming insulin resistance, and delaying intestinal glucose absorption. Key Uses & Clinical Benefits: Triple-Action Glycemic Management: Provides robust control over fasting blood glucose, postprandial (post-meal) spikes, and long-term HbA1c levels. Stimulates Natural Insulin Production: Glimepiride (a second-generation sulfonylurea) acts directly on pancreatic beta-cells to trigger phase-specific insulin release. Improves Peripheral Insulin Sensitivity: Metformin SR decreases hepatic glucose output, reduces intestinal glucose absorption, and enhances cellular insulin sensitivity in muscle tissue. Prevents Post-Meal Blood Sugar Spikes: Voglibose (an alpha-glucosidase inhibitor) delays carbohydrate digestion in the intestine, preventing sharp postprandial glucose surges. Sustained-Release Comfort: The 500 mg Sustained Release (SR) Metformin matrix ensures steady drug release throughout the day while minimizing common stomach upset and nausea. How SEIZMET TRIO 0.2 Works: Glimepiride (2 mg): Binds to sulfonylurea receptors on pancreatic beta-cells to promote glucose-dependent insulin secretion. Metformin SR (500 mg): Activates AMP-activated protein kinase (AMPK) in liver tissue to suppress gluconeogenesis and optimize insulin-mediated glucose uptake. Voglibose (0.2 mg): Competitively inhibits intestinal alpha-glucosidase enzymes, slowing the breakdown of complex carbohydrates into absorbable simple sugars.

कैसे उपयोग करें

Take 1 tablet of SEIZMET TRIO 0.2 once daily, orally immediately before or with breakfast (or the first main meal of the day), strictly as directed by your physician. Taking the medication with food helps optimize Voglibose efficacy and reduces potential gastrointestinal discomfort associated with Metformin. Swallow the tablet whole with a glass of water—do not crush, chew, or break the tablet, as doing so disrupts the sustained-release mechanism.

भंडारण

Store in a cool, dry place away from direct sunlight, light, and moisture. Store at a controlled room temperature below 30°C. Keep out of reach and sight of children.

Important guidance

Safety advice

Check with your doctor
AlcoholConsult your doctor

Avoid alcohol consumption while taking SEIZMET TRIO 0.2, as it significantly increases the risk of severe hypoglycemia and Metformin-associated lactic acidosis.

PregnancyConsult your doctor

SEIZMET TRIO 0.2 is strictly not recommended during pregnancy. Consult your physician for safer alternatives, such as insulin therapy.

BreastfeedingConsult your doctor

Do not use SEIZMET TRIO 0.2 while breastfeeding without medical advice, as active components may pass into breast milk and affect the nursing infant.

DrivingConsult your doctor

Exercise caution when driving or operating machinery. Hypoglycemia (low blood sugar) caused by Glimepiride can cause dizziness and impair focus. Always keep a fast-acting sugar source nearby.

KidneyConsult your doctor

Contraindicated in severe renal impairment . Renal function should be evaluated prior to initiating treatment and monitored regularly.

LiverConsult your doctor

Not recommended for patients with severe liver dysfunction or clinical evidence of hepatic impairment due to the increased risk of lactic acidosis and altered drug metabolism.

Clinical review pending

This page uses verified catalogue facts and responsible medicine-information rules. It supports awareness and does not replace a doctor's advice.

Customer feedback

Ratings & reviews

Be the first to review this product.

Loading reviews…

Write a review

Your feedback helps other customers make informed choices.

0/3000 charactersChecking your sign-in status…

Frequently viewed together

Rx · H
Gliempaflozin Met Er 25 And 1000 product pack

Gliempaflozin Met Er 25 And 1000

For 10 Tablets

Empagliflozin 25 mg + Metformin Hydrochloride 1000 mg

No reviews
₹161.21₹230.3030% off
Prescription required before dispatch
Rx · H
Linaliglip Empamet product pack

Linaliglip Empamet

For 15 Tablets

Empagliflozin 25 mg + Linagliptin 5 mg + Metformin 1000 mg

No reviews
₹154.00₹220.0030% off
Prescription required before dispatch
Rx · H
Acarbzone M 500 product pack

Acarbzone M 500

For 10 Tablet

Acarbose 50 mg + Metformin 500 mg

No reviews
₹108.22₹154.6030% off
Prescription required before dispatch
Rx · H
Acarbzone 25 product pack

Acarbzone 25

For 10 Tablet

Acarbose 25 mg

No reviews
₹52.83₹75.4730% off
Prescription required before dispatch

कॉल पर ऑर्डर करें

दवा की उपलब्धता, प्रिस्क्रिप्शन और अपने ऑर्डर के लिए हमारी टीम से संपर्क करें।

आपके डिवाइस का कॉल ऐप खुलेगा।